1. Home
  2. CYCN vs ULY Comparison

CYCN vs ULY Comparison

Compare CYCN & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCN
  • ULY
  • Stock Information
  • Founded
  • CYCN 2018
  • ULY 2013
  • Country
  • CYCN United States
  • ULY United States
  • Employees
  • CYCN N/A
  • ULY N/A
  • Industry
  • CYCN Biotechnology: Pharmaceutical Preparations
  • ULY
  • Sector
  • CYCN Health Care
  • ULY
  • Exchange
  • CYCN Nasdaq
  • ULY Nasdaq
  • Market Cap
  • CYCN 8.4M
  • ULY 6.7M
  • IPO Year
  • CYCN N/A
  • ULY N/A
  • Fundamental
  • Price
  • CYCN $2.88
  • ULY $0.50
  • Analyst Decision
  • CYCN
  • ULY Strong Buy
  • Analyst Count
  • CYCN 0
  • ULY 1
  • Target Price
  • CYCN N/A
  • ULY $1.50
  • AVG Volume (30 Days)
  • CYCN 5.8M
  • ULY 55.7K
  • Earning Date
  • CYCN 03-04-2025
  • ULY 03-13-2025
  • Dividend Yield
  • CYCN N/A
  • ULY N/A
  • EPS Growth
  • CYCN N/A
  • ULY N/A
  • EPS
  • CYCN N/A
  • ULY 7.18
  • Revenue
  • CYCN $194,000.00
  • ULY $155,926,000.00
  • Revenue This Year
  • CYCN N/A
  • ULY N/A
  • Revenue Next Year
  • CYCN N/A
  • ULY $4.29
  • P/E Ratio
  • CYCN N/A
  • ULY $0.07
  • Revenue Growth
  • CYCN N/A
  • ULY N/A
  • 52 Week Low
  • CYCN $1.27
  • ULY $0.41
  • 52 Week High
  • CYCN $9.47
  • ULY $3.45
  • Technical
  • Relative Strength Index (RSI)
  • CYCN 45.87
  • ULY 46.74
  • Support Level
  • CYCN $2.89
  • ULY $0.47
  • Resistance Level
  • CYCN $4.80
  • ULY $0.55
  • Average True Range (ATR)
  • CYCN 0.73
  • ULY 0.04
  • MACD
  • CYCN -0.10
  • ULY 0.00
  • Stochastic Oscillator
  • CYCN 18.73
  • ULY 38.14

About CYCN Cyclerion Therapeutics Inc.

Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: